SALVACYL

This brand name is authorized in Austria, France, Ireland, Netherlands, Poland, UK.

Active ingredients

The drug SALVACYL contains one active pharmaceutical ingredient (API):

1
UNII 9081Y98W2V - TRIPTORELIN
 

Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins.
 
Read more about Triptorelin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 SALVACYL Powder and solvent for prolonged-release suspension for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L02AE04 Triptorelin L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 69847994
GB Medicines & Healthcare Products Regulatory Agency 347326
NL Z-Index G-Standaard, PRK 77615
PL Rejestru Produktów Leczniczych 100340690

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈